Th. Cheung et al., C-FOS OVEREXPRESSION IS ASSOCIATED WITH THE PATHONEOGENESIS OF INVASIVE CERVICAL-CANCER, Gynecologic and obstetric investigation, 43(3), 1997, pp. 200-203
The molecular genetics of human cervical cancer remains to be defined
to a significant extent. The current study examined the prevalence and
significance of proto-oncogene c-fos overexpression in cervical cance
r. Immunohistochemical staining of c-fos oncoprotein was performed in
27 invasive cervical carcinomas and 30 cervical intraepithelial neopla
sias (CINs) managed in our department. Eight normal cervical specimens
were used as controls. In the patients with invasive cervical cancer,
8 were stage I, 12 were stage II, and 7 had stage III-IV disease. Thr
ee of the cancers were well differentiated, 18 were moderately differe
ntiated and 6 were poorly differentiated. Twenty invasive cervical car
cinomas (59%) and 3 CIN (10%) showed overexpression of c-fos. The diff
erence is statistically significant (p < 0.001). No statistically sign
ificant relationship was found between c-fos overexpression and clinic
al stage, histological grade, or survival in invasive cervical cancer.
In this population, c-fos overexpression appears to be common in inva
sive cervical cancer and correlated with the ability of the tumor to b
ecome invasive, but is not associated with the progression of cervical
cancer.